These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus. Friedberg SJ; Lam YW; Blum JJ; Gregerman RI Metabolism; 2006 May; 55(5):614-9. PubMed ID: 16631437 [TBL] [Abstract][Full Text] [Related]
3. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. Wilinska ME; Chassin LJ; Schaller HC; Schaupp L; Pieber TR; Hovorka R IEEE Trans Biomed Eng; 2005 Jan; 52(1):3-12. PubMed ID: 15651559 [TBL] [Abstract][Full Text] [Related]
4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
5. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
6. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Ott P; Keiding S; Bass L Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277 [TBL] [Abstract][Full Text] [Related]
8. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072 [TBL] [Abstract][Full Text] [Related]
9. [Effect of insulin-binding antibodies on the kinetics of intra- venous insulin in diabetes mellitus]. Dreva'l AV; Gite'l EP; Dreva'l TP Lab Delo; 1989; (10):41-7. PubMed ID: 2481073 [TBL] [Abstract][Full Text] [Related]
10. Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats. Philippe J; Halban PA; Gjinovci A; Duckworth WC; Estreicher J; Renold AE J Clin Invest; 1981 Mar; 67(3):673-80. PubMed ID: 6451633 [TBL] [Abstract][Full Text] [Related]
11. [From the concept of fast acting analogs to the properties of the insulin Lispro]. Selam JL Diabetes Metab; 1997 Sep; 23 Suppl 3():45-9. PubMed ID: 9410552 [TBL] [Abstract][Full Text] [Related]
12. Diminished insulin clearance during late pregnancy in patients with type I diabetes mellitus. Björklund AO; Adamson UK; Lins PE; Westgren LM Clin Sci (Lond); 1998 Sep; 95(3):317-23. PubMed ID: 9730851 [TBL] [Abstract][Full Text] [Related]
13. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
14. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis. De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors. Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations. Tarín C; Teufel E; Picó J; Bondia J; Pfleiderer HJ IEEE Trans Biomed Eng; 2005 Dec; 52(12):1994-2005. PubMed ID: 16366223 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique. Becker RH; Frick AD; Burger F; Scholtz H; Potgieter JH Exp Clin Endocrinol Diabetes; 2005 May; 113(5):292-7. PubMed ID: 15926116 [TBL] [Abstract][Full Text] [Related]
18. The clinical pharmacokinetics of vinorelbine (Navelbine). Wargin WA; Lucas VS Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans. Angst MS; Dyck JB; Azarnoff DL; Goldblum R; Ho B; Gfroerer T; Linton EA; Glynn BP; Shafer SL Clin Pharmacol Ther; 1998 Nov; 64(5):499-510. PubMed ID: 9834042 [TBL] [Abstract][Full Text] [Related]
20. Reduced insulin clearance in normal subjects due to extreme hyperinsulinemia. Nestler JE; Clore JN; Blackard WG Am J Med Sci; 1988 Jan; 295(1):15-22. PubMed ID: 3276188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]